首页> 外文期刊>Applied and Environmental Microbiology >Enhanced emulsan production in mutants of Acinetobacter calcoaceticus RAG-1 selected for resistance to cetyltrimethylammonium bromide.
【24h】

Enhanced emulsan production in mutants of Acinetobacter calcoaceticus RAG-1 selected for resistance to cetyltrimethylammonium bromide.

机译:选择对乙酰十六烷基三甲基溴化铵具有抗性的钙乙酸不动杆菌RAG-1突变体提高了乳胶生产。

获取原文
获取外文期刊封面目录资料

摘要

Mutants of Acinetobacter calcoaceticus RAG-1 that produced elevated levels of the polymeric bioemulsifier emulsan were isolated on the basis of their resistance to the cationic surfactant cetyltrimethylammonium bromide (CTAB). Such mutants showed maximum enhancement in both overall yield and specific productivity of some two- to threefold over that of the wild type. In addition, the effect was also observed in a resting cell system in the presence of chloramphenicol, indicating that the mutation is not simply the result of faster growth. When CTAB-tolerant mutants were subjected together with the sensitive parent to the detergent under growing conditions, only the mutants were found to grow. The results suggest that the mutation for CTAB resistance leads to enhanced capsule production. This was confirmed quantitatively by a specific enzyme-linked immunosorbent assay for the cell-bound emulsan minicapsule.
机译:基于其对阳离子表面活性剂溴化十六烷基三甲基铵的抗性,分离出产生高水平的聚合生物乳化剂乳聚糖的不动杆菌不动杆菌RAG-1突变体。这样的突变体显示出总产量和比生产率的最大增强是野生型的约2-3倍。此外,在氯霉素存在的静止细胞系统中也观察到了这种作用,表明该突变不仅仅是简单的快速生长的结果。当在生长条件下将耐CTAB的突变体与敏感亲本一起置于去污剂中时,仅发现突变体在生长。结果表明,CTAB耐药性突变导致胶囊产量增加。通过针对细胞结合的乳聚糖微胶囊的特异性酶联免疫吸附法定量证实了这一点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号